Endothelial progenitor cells are selectively mobilised immediately after coronary artery bypass grafting or valve surgery

Thrombosis and Haemostasis

Volumn 101, Issue 5, 2009, Pages 983-985

  Smadja, David M ^a,b,c   Godier, Anne ^a,b,c   Susen, Sophie ^d   Packard, René R S ^e   Fabiani, Jean Noël ^a,c   Aiach, Martine ^a,b,c   Gaussem, Pascale ^a,b,c  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b INSERM   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d UNIV LILLE   (France)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

BLOOD SAMPLING; CARDIOVASCULAR RISK; CORONARY ARTERY BYPASS GRAFT; CYTOKINE RELEASE; ENDOTHELIUM CELL; EXTRACORPOREAL CIRCULATION; FEMALE; HEART VALVE SURGERY; HUMAN; LABORATORY TEST; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STEM CELL;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CELL MOVEMENT; COLONY-FORMING UNITS ASSAY; CORONARY ARTERY BYPASS; ENDOTHELIAL CELLS; FEMALE; HEART VALVES; HUMANS; MALE; PROSPECTIVE STUDIES; STEM CELLS; TREATMENT OUTCOME;

EID: 66149170087     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH08-12-0798     Document Type: Letter

References (29)

1. Smadja DM, Cornet A, Emmerich J, et al. Endothelial progenitor cells: Characterization, in vitro expansion, and prospects for autologous cell therapy. Cell Biol Toxicol 2007; 23: 223-239.
2. Hill JM, Zalos G, Halcox JP, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
3. Hristov M, Zernecke A, Liehn EA, et al. Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost 2007; 98: 274-277.
4. Ergun S, Tilki D, Hohn HP, et al. Potential implications of vascular wall resident endothelial progenitor cells. Thromb Haemost 2007; 98: 930-939.
5. Scheubel RJ, Zorn H, Silber RE, et al. Age-dependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42: 2073-2080.
6. Gill M, Dias S, Hattori K, et al. Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells. Circ Res 2001; 88: 167-174.
7. Roberts N, Xiao Q, Weir G, et al. Endothelial progenitor cells are mobilized after cardiac surgery. Ann Thorac Surg 2007; 83: 598-605.
8. Ruel M, Suuronen EJ, Song J, et al. Effects of off-pump versus on-pump coronary artery bypass grafting on function and viability of circulating endothelial progenitor cells. J Thorac Cardiovasc Surg 2005; 130: 633-639.
9. Mieno S, Ramlawi B, Boodhwani M, et al. Role of stromal-derived factor-1alpha in the induction of circulating CD34+CXCR4+ progenitor cells after cardiac surgery. Circulation 2006; 114 (1 Suppl): I186-192.
10. Cesari F, Caporale R, Marcucci R, et al. NT-proBNP and the anti-inflammatory cytokines are correlated with endothelial progenitor cells' response to cardiac surgery. Atherosclerosis 2008; 199: 138-146.
11. Van Craenenbroeck EM, Conraads VM, Van Bockstaele DR, et al. Quantification of circulating endothelial progenitor cells: A methodological comparison of six flow cytometric approaches. J Immunol Methods 2008; 332: 31-40.
12. Smadja DM, Bieche I, Silvestre JS, et al. Bone morphogenetic proteins 2 and 4 are selectively expressed by late outgrowth endothelial progenitor cells and promote neoangiogenesis. Arterioscler Thromb Vasc Biol 2008; 28: 2137-2143.
13. Smadja DM, Gaussem P, Mauge L, et al. Circulating endothelial cells. A new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation 2009;in press.
14. Smadja DM, Bieche I, Susen S, et al. Interleukin 8 is differently expressed and modulated by PAR-1 activation in early and late endothelial progenitor cells. J Cell Mol Med 2009; in press.
15. Kissel CK, Lehmann R, Assmus B, et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J Am Coll Cardiol 2007; 49: 2341-2349.
16. Yang C, Zhang ZH, Li ZJ, et al. Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb Haemost 2004; 91: 1202-1212.
17. Delorme B, Basire A, Gentile C, et al. Presence of endothelial progenitor cells, distinct from mature endothelial cells, within human CD146+ blood cells. Thromb Haemost 2005; 94: 1270-1279.
18. George J, Shmilovich H, Deutsch V, et al. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 2006;12: 331-335.
19. Leone AM, Rutella S, Bonanno G, et al. Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 2005; 26: 1196-1204.
20. Schmidt-Lucke C, Rossig L, Fichtlscherer S, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005; 111: 2981-2987.
21. Werner N, Kosiol S, Schiegl T, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353: 999-1007.
22. Sturiale A, Coppolino G, Loddo S, et al. Effects of haemodialysis on circulating endothelial progenitor cell count. Blood Purif 2007; 25: 242-251.
23. Herbrig K, Pistrosch F, Oelschlaegel U, et al. Increased total number but impaired migratory activity and adhesion of endothelial progenitor cells in patients on long-term hemodialysis. Am J Kidney Dis 2004; 44: 840-849.
24. Redondo S, Hristov M, Gumbel D, et al. Biphasic effect of pioglitazone on isolated human endothelial progenitor cells: involvement of peroxisome proliferator-activated receptor-gamma and transforming growth factor-beta1. Thromb Haemost 2007; 97: 979-987.
25. Hristov M, Fach C, Becker C, et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 2007; 192: 413-420.
26. Deschaseaux F, Selmani Z, Falcoz PE, et al. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors. Eur J Pharmacol 2007; 562: 111-118.
27. Strehlow K, Werner N, Berweiler J, et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003; 107: 3059-3065.
28. Fadini GP, de Kreutzenberg S, Albiero M, et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol 2008; 28: 997-1004.
29. Di Stefano R, Barsotti MC, Melillo E, et al. The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia. Thromb Haemost 2008; 100: 871-877.